Gene delivery systems can target specific brain cells, a breakthrough that could lead to treatments for Parkinson's, ...

A U.S. senator is asking the FDA how it will enforce regulations on pharmaceutical advertising after it let go of numerous ...

Momentum Biotechnologies ("Momentum"), a contract research organization specializing in mass spectrometry-based drug discovery and proteomics, announced today the appointment of two new members to its ...

Thermo Fisher Scientific, the world leader in serving science, will showcase some of the technologies that have helped power precision oncology at the 2025 American Society of Clinical Oncology (ASCO) ...

Presentations highlight cutting-edge research in mitochondrial and neurodegeneration medicine, neurodegeneration, ...

As founder of HUYA Bioscience International, Lady Mireille Gillings built a pioneering model to accelerate the global development of novel biopharmaceutical therapies originating in China.

Researchers have developed a machine learning model called DreaMS, which significantly accelerates the analysis of previously unknown molecules. The study is published in Nature Biotechnology.

AMP-945 – discovered at the former Cancer Therapeutics Cooperative Research Centre – works by suppressing a bodily agent ...

ATX-559, a first-in-class oral DHX9 inhibitor, is being evaluated in a Phase 1/2 study with a focuson advanced or metastatic ...

Abstract: Drug function study is vital in current drug discovery, design, and development. Determining the drug functions of a novel drug is time-consuming, complicated, expensive, and requires many ...

Following the presentation titled ‘Discovering Targeted Glue™ degraders with Amphista's Eclipsys® platform’, Simon Gilbert, PhD, Presenting Author and Associate Director Discovery Biology at Amphista ...

Abstract: Due to the time and cost problems with traditional drug discovery, new methods must be found to increase the declining efficiency of traditional approaches. Virtual Screening (VS) is one ...